In addition to being tumor-suppressive in lymphomas, Gα13 has also been reported to be tumor-suppressive in vitro in melanoma [110,111], glioma [112], and in genetically engineered KRas/Tp53 pancreatic cancer mouse models [113]. The gene discussed is KRAS; the disease is neoplasm.